Twenty-Four-Hour Blood Pressure–Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension: Results From the Randomized, Placebo-Controlled SACRA Study

BACKGROUND: The risk of cardiovascular disease and mortality in salt-sensitive patients with diabetes mellitus and uncontrolled nocturnal hypertension is high. The SACRA (Sodium-Glucose Cotransporter 2 [SGLT2] Inhibitor and Angiotensin Receptor Blocker [ARB] Combination Therapy in Patients With Diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Kario, Kazuomi, Okada, Kenta, Kato, Mitsutoshi, Nishizawa, Masafumi, Yoshida, Tetsuro, Asano, Tsuguyoshi, Uchiyama, Kazuaki, Niijima, Yawara, Katsuya, Tomohiro, Urata, Hidenori, Osuga, Jun-ichi, Fujiwara, Takeshi, Yamazaki, Shoji, Tomitani, Naoko, Kanegae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493695/
https://www.ncbi.nlm.nih.gov/pubmed/30586745
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.037076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493695/
https://www.ncbi.nlm.nih.gov/pubmed/30586745
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.037076

Ejemplares similares